Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Vet J ; 170(2): 237-42, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16129343

RESUMO

The pharmacokinetics of amoxicillin (Amx) were determined in pigs following intravenous (IV) administration of a single dose of 15 mg/kg and a single dose of 15 mg/kg of a new oral formulation (Amx-FP containing 10% amoxicillin). Residue studies were performed to determine residues in edible tissues of healthy pigs after chronic oral administration of Amx-FP at a daily dose of 15 mg/kg for five consecutive days. After IV administration, the plasma concentration was characteristic of a two-compartment open model. The main pharmacokinetic variables were: t(1/2lambda(n)), MRT=90.1 min, V(darea)=0.81 L/kg and Cl(b)=3.9 mL/kg/min. After single oral administration the main pharmacokinetic variables were: C(max)=758 mug/L, t(max)=347 min and Cl(b/f)=3.7 mL/kg/min for Amx-FP. The oral bioavailability (F) was calculated at 11% for Amx-FP. Based on maximum residue levels (MRL) for AMX in pigs established at 50 microg/kg for all tissues, the withdrawal times of AMX in muscle and skin plus fat were estimated (95% tolerance limit and 95% confidence) to fall below the MRL after a withdrawal period of seven days. Levels of AMX in the liver and kidneys were estimated to fall below the MRL after a withdrawal period of four days.


Assuntos
Amoxicilina/administração & dosagem , Amoxicilina/farmacocinética , Antibacterianos/administração & dosagem , Antibacterianos/farmacocinética , Resíduos de Drogas , Suínos , Amoxicilina/sangue , Animais , Antibacterianos/sangue , Área Sob a Curva , Esquema de Medicação , Meia-Vida , Injeções Intravenosas , Distribuição Tecidual
2.
J Chromatogr Sci ; 49(10): 745-52, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22080801

RESUMO

A new HPLC procedure with precolumn derivatization and rimantadine as the internal standard for determining memantine, a candidate agent for the treatment of glaucoma in plasma and vitreous humour, has been developed and validated. Precolumn derivatization was performed with 9-fluorenylmethyl-chloroformate-chloride (FMOC-Cl) as the derivatization reagent and followed by a liquid-liquid extraction with n-hexane. Optimal conditions for derivatization were an FMOC-Cl concentration of 1.5 mM, a reaction time of 20 min, the temperature at 30°C, the borate buffer pH 8.5, and a borate buffer-acetonitrile ratio of 1:1. The derivatives were analyzed by isocratic HPLC with the fluorescence detector λex 260 nm λem 315 nm on a Novapack C(18) reversed-phase column with a mobile phase of acetonitrile-water (73:27, v/v), 40°C, and a flow rate of 1.2 mL/min. The linear range was 10-1000 ng/mL with a quantification limit of ∼ 10 ng/mL for both types of samples. This analytical method may be suitable for using in ocular availability studies.


Assuntos
Cromatografia Líquida de Alta Pressão/métodos , Memantina/análise , Espectrometria de Fluorescência/métodos , Corpo Vítreo/química , Animais , Estabilidade de Medicamentos , Fluorenos/química , Hexanos/química , Concentração de Íons de Hidrogênio , Modelos Lineares , Memantina/sangue , Memantina/química , Memantina/farmacocinética , Coelhos , Reprodutibilidade dos Testes , Rimantadina/análise , Rimantadina/sangue , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA